India's Shivalik Rasayan up as U.S. FDA completes inspection at Gujarat factory
** Shares of agrochemicals and active pharma ingredients
(API) maker Shivalik Rasayan SIVA.NS rise 5% to 590.35 rupees
** Co says U.S. Food and Drug Administration completed
inspection at its Dahej factory, Gujarat, with seven procedural
observations
** Shares down 20% YTD after falling 2.6% in 2023
(Reporting by Sethuraman NR in Bengaluru)
((Sethuraman.NR@thomsonreuters.com; (+91 9945291420); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))
Recent news on Shivalik Rasayan
See all newsBrief: Shivalik Rasayan Ltd March-Quarter Consol Net Profit 45.3 Million Rupees
Brief: Shivalik Rasayan Says US FDA Approved API Facility At Dahej
India's Shivalik Rasayan climbs on US FDA approval for facility
India's Shivalik Rasayan up as U.S. FDA completes inspection at Gujarat factory
Brief: Shivalik Rasayan Says US FDA Completes Inspection At API Facility At Dahej Unit